| Last update: 18.09.2026 15:33:14 |
Hepatology Hot Topics 2026 | ||||
| 08:30 - 10:00 | Hepatology Hot Topics 2026 Chair: Annalisa Berzigotti, Bern / Beat Müllhaupt, Zürich | |||
| 08:30 - 08:52 | MASLD: the endocrinologist point of view to a rational approach in the era of GLP1RA Cyrielle Caussy, Lyon | 18.09.26 07:55 | ||
| 08:52 - 09:14 | Portal Hypertension in 2026: a summary of the Baveno VIII consensus conference Thomas Reiberger, Wien | 17.09.26 14:05 | ||
| 09:14 - 09:36 | Endohepatology: Indications, challenges and opportunities Ilaria Tarantino, Palermo | 17.09.26 16:53 | ||
| 09:38 - 10:00 | Managing Cholestatic Pruritus in 2026: Where Do IBATs Fit? Andreas Kremer, Zürich | 17.09.26 11:10 | ||
Lunch Symposium Schwabe Pharma: "Functional Dyspepsia and IBS in Practice: A Gut-Brain Update with New Phase IV Evidence | ||||
| 12:15 - 12:45 | Lunch Symposium Schwabe Pharma: "Functional Dyspepsia and IBS in Practice: A Gut-Brain Update with New Phase IV Evidence Chair: Jeanine Wakim El-Khoury, Lausanne / Ioannis Linas, Bern | 18.09.26 11:54 | ||
Lunch Symposium Ipsen Pharma Schweiz GmbH: Seeing the Unseen: Uncovering Genetic Cholestatic Diseases in Everyday Hepatology Practice | ||||
| 12:50 - 13:20 | Lunch Symposium Ipsen Pharma Schweiz GmbH: Seeing the Unseen: Uncovering Genetic Cholestatic Diseases in Everyday Hepatology Practice Chair: ValÉrie McLin, Genève / Andreas Kremer, Zürich | 18.09.26 09:31 | ||
Hepatology oral presentations II | ||||
| 13:30 - 15:00 | Hepatology oral presentations II Chair: Andreas Kremer, Zürich / Magdalena Filipowicz Sinnreich, Liestal | |||
| 13:30 - 13:55 | Machine perfusion Philipp Dutkowski, Basel | 18.09.26 11:38 | ||
| 14:00 - 14:10 | Discovery of Novel MRGPRX4 Agonists and Antagonists with Implications for Hepatobiliary Pruritus Silvia Pickering, Zurich | 18.09.26 12:08 | ||
| 14:10 - 14:20 | Pharmacological effects of edoxaban and apixaban in patients with liver cirrhosis Montserrat Fraga, Lausanne | 18.09.26 10:38 | ||
| 14:20 - 14:30 | Atezolizumab/Bevacizumab for Recurrent Hepatocellular Carcinoma After Liver Transplantation: First Swiss Experience Hala Alrasheed, St. Gallen | 18.09.26 11:13 | ||
| 14:30 - 14:40 | Selective Targeting Of The Blood-Biliary Barrier Ameliorates Fibrotic and Cholestatic Liver Damage by Enhancing Bicarbonate Secretion and Bile Dynamics. Felix Baier, Bern | 18.09.26 08:57 | ||
| 14:40 - 14:50 | Early disease activity assessment in patients with alveolar echinococcosis: a Swiss single-centre retrospective study. Jakob Heinkele, Zürich | 18.09.26 10:48 | ||
| 14:50 - 15:00 | Predictive Factors For Explantation Or Mortality After Tunneled Peritoneal Catheters In Patients With Cirrhosis And Refractory Ascites : A Swiss Multicentre Retrospective Study Herr JÉrÉmy Hassoun, Geneve | 18.09.26 09:07 | ||
Abdominal Sonography Course (SGUM accreditated, separate inscription: office@sggssg.ch) | ||||
| 15:30 - 17:00 | Abdominal Sonography Course (SGUM accreditated, separate inscription: office@sggssg.ch) Chair: Irina Bergamin, St. Gallen / Pamela Meyer-Herbon, St. Gallen / Livia Kammerlander, Winterthur | 18.09.26 13:04 | ||